Absence of Macrolide-Resistant Mutations in Bordetella pertussis in Antananarivo (Madagascar) and Cambodia During the Last Pertussis Cycle Before the COVID-19 Pandemic
Year: 2025
Type: article
Abstract: Macrolides are the first-line treatment against pertussis. The high prevalence of macrolide-resistant Bordetella pertussis (MRBP) strains reported in China is concerning. MBRP might be underestimated in other countries. Looking for the mutation causative for MRBP in retrospective studies conducted in Madagascar and Cambodia, we found no MRBP.
Source: Open Forum Infectious Diseases
DOI: 10.1093/ofid/ofaf566
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,053
Funder: Total Foundation
OpenAlex ID: W4414368017
